Trosa, Sweden

Karin Hellström


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karin Hellström: Innovator in Anti-Inflammatory Therapies

Introduction

Karin Hellström is a notable inventor based in Trosa, Sweden. She has made significant contributions to the field of medicine, particularly in the development of therapies for inflammatory diseases. Her innovative approach has led to the creation of a unique method aimed at enhancing the effectiveness of anti-inflammatory treatments.

Latest Patents

Karin holds a patent for a composition and method for the prevention, treatment, and/or alleviation of an inflammatory disease. This patent describes a method for enhancing clinical responsiveness to anti-inflammatory therapy in patients suffering from inflammatory conditions. The method involves administering an oligonucleotide with a specific sequence in an effective amount to the patient. The invention also includes the use of this oligonucleotide for manufacturing a medicament that enhances steroid efficacy in treating inflammatory conditions. She has 1 patent to her name.

Career Highlights

Karin is associated with Index Pharmaceuticals AB, where she continues to work on innovative solutions in the pharmaceutical industry. Her research focuses on improving treatment outcomes for patients with inflammatory diseases, showcasing her commitment to advancing medical science.

Collaborations

Karin collaborates with Oliver Von Stein, contributing to the development of new therapeutic strategies. Their partnership exemplifies the importance of teamwork in driving innovation in healthcare.

Conclusion

Karin Hellström's work in the field of anti-inflammatory therapies highlights her role as a pioneering inventor. Her contributions are vital in enhancing treatment options for patients with inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…